Jain Global’s ProKidney PROK Stock Holding History

Jain Global’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,305	Closed	-$91.8K	–	1984
2026 Q1	$91.8K	Buy	+51,305	New	+$109K	﹤0.01%	1131
2025 Q3	–	Sell	-112,406	Closed	-$66.6K	–	1396
2025 Q2	$66.6K	Buy	+112,406	New	+$87.5K	﹤0.01%	1073

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jain Global's PROK Position: Q2 2026 in Review

Jain Global sold out of ProKidney (PROK) in Q2 2026, closing a stake of 51,305 shares — an estimated $91.8K sold.

Jain Global first reported a position in PROK in Q2 2025 and held it in 2 quarters. The position peaked at $91.8K in Q1 2026. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

Jain Global reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
Jain Global sold 51,305 ProKidney shares in Q2 2026, an estimated $91.8K.
Jain Global first reported a position in ProKidney in Q2 2025 and held it in 2 quarters.
Jain Global's ProKidney position peaked at $91.8K in Q1 2026.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.